Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial.
BMC Nephrol
; 24(1): 117, 2023 04 28.
Article
in En
| MEDLINE
| ID: mdl-37118685
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
BMC Nephrol
Journal subject:
NEFROLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Reino Unido